{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:20:16Z","timestamp":1790767216436,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/spc.0000000000000093","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T12:50:17Z","timestamp":1411649417000},"page":"346-351","source":"Crossref","is-referenced-by-count":36,"title":["Role of corticosteroids for fatigue in advanced incurable cancer"],"prefix":"10.1097","volume":"8","author":[{"given":"Sriram","family":"Yennurajalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20211004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","article-title":"Symptom prevalence in patients with incurable cancer: a systematic review.","volume":"34","author":"Teunissen","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"R2-7-20211004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpainsymman.2007.02.040","article-title":"Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice.","volume":"35","author":"Butt","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R3-7-20211004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpainsymman.2010.03.017","article-title":"Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic.","volume":"41","author":"Yennurajalingam","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"R4-7-20211004","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jpainsymman.2011.12.279","article-title":"Differences in fatigue experiences among patients with advanced cancer, cancer survivors, and the general population.","volume":"44","author":"de Raaf","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"R6-7-20211004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain.","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"R7-7-20211004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface.","volume":"14","author":"Grace","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R8-7-20211004","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jpain.2010.01.271","article-title":"Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming.","volume":"11","author":"Hains","year":"2010","journal-title":"J Pain"},{"key":"R9-7-20211004","doi-asserted-by":"crossref","first-page":"e81234","DOI":"10.1371\/journal.pone.0081234","article-title":"Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research.","volume":"8","author":"Cheung","year":"2013","journal-title":"PLoS One"},{"key":"R10-7-20211004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00520-011-1158-0","article-title":"Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.","volume":"20","author":"Janelsins","year":"2012","journal-title":"Support Care Cancer"},{"key":"R11-7-20211004","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R13-7-20211004","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s11136-010-9757-7","article-title":"Im so tired: biological and genetic mechanisms of cancer-related fatigue.","volume":"19","author":"Barsevick","year":"2010","journal-title":"Qual Life Res"},{"key":"R14-7-20211004","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1258\/ebm.2011.011028","article-title":"Role of nuclear factor-B-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.","volume":"236","author":"Gupta","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"R15-7-20211004","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbi.2012.02.001","article-title":"Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.","volume":"26","author":"Liu","year":"2012","journal-title":"Brain Behav Immun"},{"key":"R16-7-20211004","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/jpm.2011.0002","article-title":"Physician-reported corticosteroid therapy practices in certified palliative care units in Japan: a nationwide survey.","volume":"14","author":"Matsuo","year":"2012","journal-title":"J Palliat Med"},{"key":"R17-7-20211004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/02841860500401167","article-title":"The use of corticosteroids in Swedish palliative care.","volume":"45","author":"Lundstrom","year":"2006","journal-title":"Acta Oncol"},{"key":"R18-7-20211004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/J354v21n04_14","article-title":"Role of Corticosteroids in Palliative Care.","volume":"21","author":"Shih","year":"2007","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"R19-7-20211004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-684X-13-7","article-title":"Corticosteroid prescribing in palliative care settings: a retrospective analysis in New Zealand.","volume":"13","author":"Denton","year":"2014","journal-title":"BMC Palliat Care"},{"key":"R21-7-20211004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpainsymman.2004.01.009","article-title":"Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial.","volume":"28","author":"Bruera","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"R22-7-20211004","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexiacachexia.","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J Clin Oncol"},{"key":"R23-7-20211004","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/0277-5379(89)90354-4","article-title":"Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group.","volume":"25","author":"Popiela","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R24-7-20211004","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/0277-5379(89)90353-2","article-title":"Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group.","volume":"25","author":"Della Cuna","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R25-7-20211004","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V","article-title":"Corticosteroid therapy of preterminal gastrointestinal cancer.","volume":"33","author":"Moertel","year":"1974","journal-title":"Cancer"},{"key":"R26-7-20211004","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","article-title":"Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.","volume":"31","author":"Yennurajalingam","year":"2013","journal-title":"J Clin Oncol"},{"key":"R27-7-20211004","first-page":"751","article-title":"Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study.","volume":"69","author":"Bruera","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"R28-7-20211004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/bmj.288.6410.27","article-title":"Prednisolone as an appetite stimulant in patients with cancer.","volume":"288","author":"Willox","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R29-7-20211004","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1200\/JCO.2000.18.19.3409","article-title":"Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence.","volume":"18","author":"Ioannidis","year":"2000","journal-title":"J Clin Oncol"},{"key":"R30-7-20211004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2004.06.003","article-title":"Diurnal cortisol rhythm and fatigue in breast cancer survivors.","volume":"30","author":"Bower","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"R31-7-20211004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbi.2006.08.001","article-title":"Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids.","volume":"21","author":"Bower","year":"2007","journal-title":"Brain Behav Immun"},{"key":"R32-7-20211004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.psyneuen.2013.11.006","article-title":"Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus.","volume":"40","author":"Frank","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"R33-7-20211004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-0173(96)00012-4","article-title":"The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions.","volume":"23","author":"McEwen","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"R34-7-20211004","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids: new mechanisms for old drugs.","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"R35-7-20211004","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls.","volume":"4","author":"Dietrich","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R36-7-20211004","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"R37-7-20211004","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia.","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"R39-7-20211004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1049909106295431","article-title":"A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients.","volume":"24","author":"Mercadante","year":"2007","journal-title":"Am J Hosp Palliat Care"},{"key":"R41-7-20211004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bjc.6603048","article-title":"Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy.","volume":"94","author":"Vardy","year":"2006","journal-title":"Br J Cancer"},{"key":"R42-7-20211004","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy.","volume":"45","author":"Schakman","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"R44-7-20211004","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jpainsymman.2011.04.011","article-title":"Corticosteroid rotation to alleviate dexamethasone-induced hiccup: a case series at a single institution.","volume":"43","author":"Kang","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"R45-7-20211004","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1634\/theoncologist.2013-0224","article-title":"Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation.","volume":"18","author":"Lee","year":"2013","journal-title":"Oncologist"},{"key":"R46-7-20211004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/026921601673324846","article-title":"A prospective survey of the use of dexamethasone on a palliative care unit.","volume":"15","author":"Hardy","year":"2001","journal-title":"Palliat Med"},{"key":"R47-7-20211004","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00520-007-0395-8","article-title":"The use and toxicity of steroids in the management of patients with brain metastases.","volume":"16","author":"Sturdza","year":"2008","journal-title":"Support Care Cancer"},{"key":"R48-7-20211004","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/WNL.48.5.1234","article-title":"Steroid myopathy in cancer patients.","volume":"48","author":"Batchelor","year":"1997","journal-title":"Neurology"},{"key":"R49-7-20211004","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","article-title":"Corticosteroid-induced adverse events in adults: frequency, screening and prevention.","volume":"30","author":"Fardet","year":"2007","journal-title":"Drug Saf"},{"key":"R50-7-20211004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy.","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"key":"R51-7-20211004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment.","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"R52-7-20211004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00008483-199703000-00002","article-title":"Glucocorticoid-induced muscle atrophy: the role of exercise in treatment and prevention.","volume":"17","author":"LaPier","year":"1997","journal-title":"J Cardiopulm Rehabil"},{"key":"R53-7-20211004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005768-199804000-00003","article-title":"Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients.","volume":"30","author":"Braith","year":"1998","journal-title":"Med Sci Sports Exerc"},{"key":"R54-7-20211004","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/jpm.2012.0146","article-title":"The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.","volume":"15","author":"Yennurajalingam","year":"2012","journal-title":"J Palliat Med"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201412000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T13:45:38Z","timestamp":1633527938000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201412000-00007"}},"subtitle":["is it a \u2018wonder drug\u2019 or \u2018deal with the devil\u2019"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000093","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}